CONTACT
Home
About Us
ImmunoCellular History
Board of Directors
Contact Us
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Investors
Press Releases
Events & Presentations
Stock information
Historic stock lookup
Investment Calculator
Dividend Policy
Ownership Profile
Financial Information
Key ratios
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
RSS Feeds
Business Development
MENU
Home
About Us
ImmunoCellular History
Board of Directors
Contact Us
Technology
Cancer Immunotherapy
Stem-to-T-Cell Platform
Dendritic Cell-Based Immunotherapeutics
Dendritic Cell-Based Manufacturing
Publications
Resources
Investors
Press Releases
Events & Presentations
Stock information
Historic stock lookup
Investment Calculator
Dividend Policy
Ownership Profile
Financial Information
Key ratios
SEC Filings
Corporate Governance
Board of Directors
Committee Composition
RSS Feeds
Business Development
PRESS RELEASES
Wednesday, October 17, 2018
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing
read more ...
Monday, October 15, 2018
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock
read more ...
Home
About Us
Technology
Investors
Business Development
Terms of Use
|
Privacy Policy
|
Contact
Copyright 2018 by Immunocellular Therapeutics, Ltd.
All Rights Reserved
Login